Haleon (HLN) Total Liabilities (2021 - 2025)
Haleon (HLN) posted Total Liabilities of $21.5 billion for Q4 2025, down 7.51% on a QoQ basis from $23.2 billion in Q4 2024, and down 7.51% year-over-year from $23.2 billion in Q4 2024.
Haleon (HLN) Total Liabilities (2021 - 2025) Analysis & Trends
Haleon's Total Liabilities history runs 5 years deep, the most recent figure standing at $21.5 billion for Q4 2025.
- Quarterly Total Liabilities fell 7.51% year-over-year to $21.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.5 billion (down 7.51% YoY) and the FY2025 annual result came in at $21.3 billion, down 7.94% from the prior year.
- Total Liabilities was $21.5 billion for Q4 2025 at Haleon, down from $23.2 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $23.2 billion in Q4 2024 and bottomed at -$22.7 billion in Q2 2022.
- A 5-year average of $4.1 billion and a median of $16.1 billion in 2021 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 100.4% — and 2025, when it dropped 7.51%.
- Haleon's Total Liabilities stood at $10.7 billion in 2021, then surged by 100.4% to $21.5 billion in 2022, then retreated by 0.13% to $21.5 billion in 2023, then climbed by 7.98% to $23.2 billion in 2024, then fell by 7.51% to $21.5 billion in 2025.
- Business Quant data shows HLN's Total Liabilities at $21.5 billion in Q4 2025, $23.2 billion in Q4 2024, and -$21.1 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 634.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.48 Bn |
| Dec 31, 2024 | 23.22 Bn |
| Jun 30, 2024 | -21.07 Bn |
| Dec 31, 2023 | 21.50 Bn |
| Jun 30, 2023 | -22.02 Bn |
| Dec 31, 2022 | 21.53 Bn |
| Jun 30, 2022 | -22.68 Bn |
| Dec 31, 2021 | 10.74 Bn |